Business expansion
Hrvatska; Jadranska Hrvatska; Primorsko-goranska županija
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.2 - Manufacture of pharmaceutical preparations

100 jobs
Number of planned job creations
Job creation
Announcement Date
22 January 2015
Employment effect (start)
3 March 2015
Foreseen end date
1 May 2015


Jadran Galenski Laboratorij (JGL) is expanding its production facilities with the construction of a new “Pharma Valley”, which will double its output in sterile solutions and create 100 new jobs.

JGL is a flexible, medium-sized pharmaceutical company, producing primarily generics, developed from a central laboratory for manufacturing and controlling magistral and galenic preparations for the "JADRAN" Rijeka pharmacy.  It is the second largest pharmaceutical company in Croatia specialising in the production of sterile nose, eye and ear drop solutions. The company exports 75 per cent of its production. It was founded in 1991 as the first entirely private pharmaceutical joint stock company in Croatia. It is situated in Rijeka.

The European Bank for Reconstruction and Development (EBRD) is supporting the expansion of JGL with a €20 million multi-currency loan. The EBRD’s loan will be complemented by a €32.7 million loan provided by the Croatian Development Bank - HBOR. JGP serves as an example of the country’s potential in terms of entrepreneurship, innovation and know-how.  EBRD hopes that many more local companies will emulate this successful example.

The JGL Management Board is very pleased that a reputable financial institution such as the EBRD has recognised JGL as a long-term partner. The loan will finance working capital needed for its ongoing investment projects while providing additional support to JGL's strong growth and sustainable development. This will ensure the capacities for research and development, production and storage and will support JGL in taking a further strategic step in selected therapeutic areas in the global pharmaceutical market. 



  • 22 January 2015: Poslovni.hr
  • 22 January 2015: Seebiz.eu


Eurofound (2015), Jadran Galenskim Laboratorijem, Business expansion in Croatia, factsheet number 78259, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/78259.